ALB and esophageal cancer: Preoperative stenting during neoadjuvant therapy for esophageal cancer in patients planned for curative surgical treatment improved dysphagia scores after the procedure but had no beneficial effect on weight, body mass index (BMI), or albumin in the recent systematic review by Ahmed et al. ES was associated with a lower R0 resection rate and overall survival [44].